Article Information
History
- September 22, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kirstine J. Bell1,2,11,
- Sonia Saad3,11,
- Bree J. Tillett4,11,
- Helen M. McGuire1,5,6,
- Sara Bordbar7,
- Yu Anne Yap7,
- Long T. Nguyen3,
- Marc R. Wilkins8,
- Susan Corley8,
- Shannon Brodie1,
- Sussan Duong1,
- Courtney J. Wright1,2,
- Stephen Twigg1,2,
- Barbara Fazekas de St Groth1,5,6,
- Leonard C. Harrison9,
- Charles R. Mackay7,
- Esteban N. Gurzov10,
- Emma E. Hamilton-Williams4,* and
- Eliana Mariño7,12,*
- 1Charles Perkins Centre, University of Sydney, Camperdown, NSW 2050 Australia
- 2Faculty of Medicine and Health, Sydney Medical School, University of Sydney, NSW Australia
- 3Kolling Institute of Medical Research, Royal North Shore Hospital, Sydney Medical School, University of Sydney, St Leonards, NSW, Australia
- 4The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia
- 5Discipline of Pathology, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW 2050 Australia
- 6Ramaciotti Facility for Human Systems Biology, The University of Sydney, Camperdown, NSW 2050 Australia
- 7Infection and Immunity Program, Biomedicine Discovery Institute, Department of Biochemistry, Monash University, Melbourne, Victoria 3800, Australia
- 8Systems Biology Initiative, School of Biotechnology and Biomolecular Sciences, University of New South Wales, NSW, 2052, Australia
- 9Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia and Department of Medical Biology, University of Melbourne, Victoria 3010, Australia
- 10Signal Transduction and Metabolism Laboratory, Université libre de Bruxelles, Brussels 1070, Belgium
- ↵*Correspondence: e.hamiltonwilliams{at}uq.edu.au and eliana.marino{at}monash.edu
↵11 These authors contributed equally: Kirstine J. Bell, Sonia Saad, Bree J. Tillett
Posted September 22, 2021.
Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation
